Daewoong and iCOOP Selected for 'Smart Continuous Glucose Monitoring Clinic' Utilizing CGM

Daewoong Pharmaceutical announced on the 8th that it, together with iCoop, selected Cecil Internal Medicine Clinic as the first ‘Smart Continuous Glucose Monitoring (CGM) Clinic’ and held a tripartite agreement ceremony.

Professor Jo Jae-hyung of Seoul St. Mary's Hospital, Lee Chi-hoon, and Min Jun-gi, director of Cecil Internal Medicine Clinic (from left), are posing for a commemorative photo at the Smart Continuous Glucose Monitoring Clinic agreement ceremony.
[Photo by Daewoong Pharmaceutical]

This agreement was made with the purpose of applying the ‘Digital Diabetes Patient Education System’?developed through collaboration between Daewoong Pharmaceutical, which sells Abbott Korea’s continuous glucose monitor (CGM) 'FreeStyle Libre,' and iCoop, which developed the chronic disease management platform ‘DoctorVice’?to Cecil Internal Medicine Clinic for efficient diabetes management of local residents.

The Digital Diabetes Patient Education System links patients’ blood glucose fluctuation data obtained through Libre to DoctorVice, delivering personalized management strategies and related information to patients via an automated messaging system.

At clinics selected as Smart Continuous Glucose Monitoring Clinics, the screening function of the DoctorVice application (app) allows for the selection of candidates for continuous glucose monitoring tests, eliminating the inconvenience of screening. Patients selected as candidates for continuous glucose monitoring receive 27 educational messages and videos via KakaoTalk during the 14 days they wear Libre, which help improve adherence to CGM. Additionally, through the wearable device Libre, regular blood glucose monitoring and self-directed diabetes education are possible outside the clinic, enabling more effective blood glucose management.

This agreement ceremony is the first project targeting clinics following the ‘WANTED CGM Symposium’ held in March by Daewoong Pharmaceutical in collaboration with iCoop and Abbott Korea, utilizing Libre. By combining blood glucose monitoring with systematic diabetes education at primary medical institutions, it is expected to improve patients’ quality of life as well as reduce social medical expenses.

Lee Chang-jae, CEO of Daewoong Pharmaceutical, said, “We are very pleased that Cecil Internal Medicine Clinic is participating as the first Smart Continuous Glucose Monitoring Clinic together with iCoop,” adding, “Through Libre, Daewoong Pharmaceutical will play a central role not only in preventing complications in diabetes patients but also in preventing diabetes in prediabetic patients and metabolic syndrome in patients requiring weight control, thereby becoming a healthcare company that contributes to the improvement of national health.”

This content was produced with the assistance of AI translation services.